Showing 1921-1930 of 2813 results for "".
- Cynosure Hires Katie Cheng As New CMOhttps://modernaesthetics.com/news/cynosure-hires-katie-cheng-as-new-chief-marketing-office/2473038/Katie Cheng is Cynosure’s new Chief Marketing Officer. "Katie's proven track record of consumer and professional marketing strategy and execution is one of the many reasons we are eager to have Katie join our team," says Cynosure CEO Todd Tillemans, i
- Are COVID-19 Vaccines Safe for Filler Patients?https://modernaesthetics.com/news/facial-fillers-and-covid-19-vaccines-is-there-a-risk-for-adverse-reactions/2473036/Three patients with dermal fillers have had adverse reactions to the Moderna COVID-19 vaccine, according to the Aesthetic Society. The FDA intends to note this in its prescribing information. There have been no reported cases in patients receiving the Pfizer COVID-19 vaccine.
- Expert Sets Record Straight on COVID-19 Vaccine/Fillers “Risk”https://modernaesthetics.com/news/expert-sets-record-straight-on-covid-19-vaccinefillers-risk/2473033/When FDA officials reviewed the data for Moderna’s COVID-19 vaccine, a data point garnered some attention. There seemed to be at least a temporal association between treatment with dermal fillers and non-serious adverse reactions to the vaccine in three study subjects. Modern Aesth
- Developing Story: AbbVie’s Allergan Wins Trade Secret Case Against Evolushttps://modernaesthetics.com/news/developing-story-abbvies-allergan-wins-trade-secret-case-against-evolus/2473030/AbbVie Inc.’s Allergan won a U.S. trade agency order to block Evolus Inc. and its partner Daewoong Pharmaceutical Co. from importing Jeuveau into the U.S. for 21 months, according to media reports. The U.S. International Trade Commission upheld a judge’s findings that Jeuvea
- Revance Update: FDA Defers Approval of DaxibotulinumtoxinA Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspectionhttps://modernaesthetics.com/news/revance-update-fda-defers-approval-of-daxibotulinumtoxina-due-to-covid-19-related-travel-restrictions-impacting-manufacturing-site-inspection/2473027/The U.S. Food and Drug Administration (FDA) deferred a decision on the Biologics License Application (BLA) for Revance’s DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the treatment of moderate to severe glabellar lines. In a communication r
- ISAPS Reports Continuing Rise in Aesthetic Surgery Worldwidehttps://modernaesthetics.com/news/isaps-reports-continuing-rise-in-aesthetic-surgery-worldwide/2473026/Total surgical and nonsurgical cosmetic procedures increased by 7.4 percent in 2019, according to the International Society of Aesthetic Plastic Surgery (ISAPS) 2019 Global Survey. The 7.4 perce
- Martine Williamson Named Revlon’s New Chief Marketing Officerhttps://modernaesthetics.com/news/martine-williamson-named-revlons-new-chief-marketing-officer/2473025/Martine Williamson is Revlon’s new Chief Marketing Officer. In this role, Williamson will be central to creating and spearheading global strategic plans across the brand portfolio and overseeing Revlon’s overall brand equity and architecture. Williamson officially join
- ZO Skin Health Adds Colleen Goggins to Board of Directorshttps://modernaesthetics.com/news/zo-skin-health-adds-colleen-goggins-to-board-of-directors/2473024/Colleen Goggins is joining ZO Skin Health’s board of directors. This follows the recent acquisition of a majority stake in the business in October by funds managed by Blackstone Tactical Opportunities. As a partner and counsellor to a large variety of bu
- Call for Entries: Merz Aesthetics Announces First-Ever Innovation Forumhttps://modernaesthetics.com/news/call-for-entries-merz-aesthetics-announces-first-ever-innovation-forum/2473021/Merz Aesthetics is launching its first-ever Innovation Forum with a call for abstract submissions seeking the most creative and inventive medical aesthetics abstracts from the next generation of researchers and healthcare professionals. The author of the winning abstrac
- Crown Aesthetics’ SkinPen Precision Scores Class IIa CE Certification from the British Standards Institutionhttps://modernaesthetics.com/news/crown-aesthetics-skinpen-precision-scores-class-iia-ce-certification-from-the-british-standards-institution/2473019/The British Standards Institution (BSI) granted a Class IIa CE Certification mark to Crown Aesthetics’ SkinPen Precision. The certification confirms SkinPen as a treatment to improve the appearance of facial acne scars in adults aged 22 years or older and to improve the appe